Some complementary data on AH 5158, an inhibitor of both alpha-and beta-adrenoceptors [proceedings]
- PMID: 11020
- PMCID: PMC1667557
Some complementary data on AH 5158, an inhibitor of both alpha-and beta-adrenoceptors [proceedings]
Similar articles
-
[Effects of labetalol on the circulatory system (author's transl)].Nihon Yakurigaku Zasshi. 1980 May;76(4):239-54. Nihon Yakurigaku Zasshi. 1980. PMID: 6108907 Japanese.
-
[Interaction of labetalol with alpha- and beta-adrenergic receptors : biochemical study (author's transl)].Nouv Presse Med. 1978 Oct 14;7(35):3121-3. Nouv Presse Med. 1978. PMID: 31601 French.
-
The alpha- and beta-adrenoceptor blocking potencies of labetalol and its individual stereoisomers in anaesthetized dogs and in isolated tissues.Br J Pharmacol. 1982 Sep;77(1):105-14. doi: 10.1111/j.1476-5381.1982.tb09275.x. Br J Pharmacol. 1982. PMID: 6127131 Free PMC article.
-
Clinical pharmacology of labetalol.Br J Clin Pharmacol. 1979;8(Suppl 2):89S-93S. Br J Clin Pharmacol. 1979. PMID: 43165 Free PMC article. Review.
-
The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent.Gen Pharmacol. 1978;9(6):399-402. doi: 10.1016/0306-3623(78)90024-1. Gen Pharmacol. 1978. PMID: 32121 Review. No abstract available.
Cited by
-
The electrophysiological effects of intravenous labetalol in man.Eur J Clin Pharmacol. 1981;20(4):241-4. doi: 10.1007/BF00618772. Eur J Clin Pharmacol. 1981. PMID: 7308279 No abstract available.
-
Labetalol: a review of its pharmacology and therapeutic use in hypertension.Drugs. 1978 Apr;15(4):251-70. doi: 10.2165/00003495-197815040-00002. Drugs. 1978. PMID: 25757 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources